News

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...
Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...
The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...
The body that regulates charities in Britain issued a stern reprimand to a charity set up by Prince Harry over failings that ...
More and more research is showing how climate change could trigger increased migration and, with it, another obstacle in ...
A new, free-of-charge clinic in downtown Toronto is hoping to change lives for people living with human immunodeficiency ...
Gilead Sciences, Inc. (NASDAQ:GILD) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Gilead Sciences, Inc.
The Manila Times on MSN3dOpinion
Global HIV funding crisis risks rising deaths
THE issue of human immunodeficiency virus-acquired immunodeficiency syndrome (HIV-AIDS) never really left the Philippines.
The House Committee on HIV/AIDS, Tuberculosis, Leprosy and Malaria Control, has called for a radical shift in the nation's approach to HIV response, warning that the country must take full ownership ...
In Kenya, HIV funding from the U.S. in fiscal year 2024 totaled $307.9 million, equivalent to almost a third of the country’s ...
Toronto PWA Foundation and online health-care provider Freddie hope new clinic provides care to those who might otherwise ...
Of the new cases in Pangasinan this year, the youngest are two girls ages 5 and 6, said acting provincial health officer Dr.